Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-24 Sale | 2023-01-26 4:49 pm | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 100,000 | $6 | $600,000 | 479,565 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-26 Disposition | 2023-06-26 4:05 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 1,023,340 | $0 | 0 (Direct) | View |
| 2023-06-26 Equity Swap | 2023-06-26 4:05 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 3,565 | $9.1 | 0 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 5:52 pm | N/A 2033-03-14 | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-01-24 Exercise | 2023-01-26 4:49 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 100,000 | $0.9489 | 479,565 (Direct) | View |
| 2023-01-24 Exercise | 2023-01-26 4:49 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 100,000 | $0 | 479,565 (Direct) | View |
| 2019-02-19 Option Award | 2023-01-26 4:49 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 288,000 | $0 | 479,565 (Direct) | View |
Ownership | 2022-03-11 7:37 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Fong James K See Remarks | 0 | $0 | 933,395 (Direct) | View |